Cargando…

Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts

Spinal arteriovenous (AV) shunts are rare conditions that sometimes present with myelopathy symptoms. The progression of the symptoms is usually gradual; however, some cases show rapid deterioration. We retrospectively investigated the factors that induced the rapid deterioration of myelopathy sympt...

Descripción completa

Detalles Bibliográficos
Autores principales: MIYAHARA, Takahiro, HATTORI, Gohsuke, UCHIKADO, Hisaaki, KAKU, Yasuyuki, OHMORI, Yuki, ORITO, Kimihiko, TAKEUCHI, Yasuharu, KAWANO, Takayuki, HIROHATA, Masaru, MUKASA, Akitake, MORIOKA, Motohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841232/
https://www.ncbi.nlm.nih.gov/pubmed/34776462
http://dx.doi.org/10.2176/nmc.oa.2020-0439
_version_ 1784650791760429056
author MIYAHARA, Takahiro
HATTORI, Gohsuke
UCHIKADO, Hisaaki
KAKU, Yasuyuki
OHMORI, Yuki
ORITO, Kimihiko
TAKEUCHI, Yasuharu
KAWANO, Takayuki
HIROHATA, Masaru
MUKASA, Akitake
MORIOKA, Motohiro
author_facet MIYAHARA, Takahiro
HATTORI, Gohsuke
UCHIKADO, Hisaaki
KAKU, Yasuyuki
OHMORI, Yuki
ORITO, Kimihiko
TAKEUCHI, Yasuharu
KAWANO, Takayuki
HIROHATA, Masaru
MUKASA, Akitake
MORIOKA, Motohiro
author_sort MIYAHARA, Takahiro
collection PubMed
description Spinal arteriovenous (AV) shunts are rare conditions that sometimes present with myelopathy symptoms. The progression of the symptoms is usually gradual; however, some cases show rapid deterioration. We retrospectively investigated the factors that induced the rapid deterioration of myelopathy symptoms in patients with spinal AV shunts. We treated 33 patients with myelopathy with spinal AV shunts at our institutions, eight of whom experienced rapid deterioration (within 24 hours: 24.2%). Of these, three were related to the body movement or particular postures associated with playing golf, 30 minutes of Japanese straight sitting, and massage care. One patient showed deterioration after embolization for a tracheal aneurysm. The remaining four patients received steroid pulse therapy (high-dose steroid infusion) shortly before the rapid deterioration. These symptoms stopped progressing after cessation of steroid use. While positional or physical factors contributing to myelopathy deterioration might exist, we could not identify specific factors in this study. Nevertheless, rapid deterioration was frequently observed after high-dose steroid use. We must take care not to administer high-dose steroids for myelopathy caused by spinal AV shunt disease.
format Online
Article
Text
id pubmed-8841232
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japan Neurosurgical Society
record_format MEDLINE/PubMed
spelling pubmed-88412322022-02-25 Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts MIYAHARA, Takahiro HATTORI, Gohsuke UCHIKADO, Hisaaki KAKU, Yasuyuki OHMORI, Yuki ORITO, Kimihiko TAKEUCHI, Yasuharu KAWANO, Takayuki HIROHATA, Masaru MUKASA, Akitake MORIOKA, Motohiro Neurol Med Chir (Tokyo) Original Article Spinal arteriovenous (AV) shunts are rare conditions that sometimes present with myelopathy symptoms. The progression of the symptoms is usually gradual; however, some cases show rapid deterioration. We retrospectively investigated the factors that induced the rapid deterioration of myelopathy symptoms in patients with spinal AV shunts. We treated 33 patients with myelopathy with spinal AV shunts at our institutions, eight of whom experienced rapid deterioration (within 24 hours: 24.2%). Of these, three were related to the body movement or particular postures associated with playing golf, 30 minutes of Japanese straight sitting, and massage care. One patient showed deterioration after embolization for a tracheal aneurysm. The remaining four patients received steroid pulse therapy (high-dose steroid infusion) shortly before the rapid deterioration. These symptoms stopped progressing after cessation of steroid use. While positional or physical factors contributing to myelopathy deterioration might exist, we could not identify specific factors in this study. Nevertheless, rapid deterioration was frequently observed after high-dose steroid use. We must take care not to administer high-dose steroids for myelopathy caused by spinal AV shunt disease. The Japan Neurosurgical Society 2022-01 2021-11-12 /pmc/articles/PMC8841232/ /pubmed/34776462 http://dx.doi.org/10.2176/nmc.oa.2020-0439 Text en © 2022 The Japan Neurosurgical Society https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Article
MIYAHARA, Takahiro
HATTORI, Gohsuke
UCHIKADO, Hisaaki
KAKU, Yasuyuki
OHMORI, Yuki
ORITO, Kimihiko
TAKEUCHI, Yasuharu
KAWANO, Takayuki
HIROHATA, Masaru
MUKASA, Akitake
MORIOKA, Motohiro
Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts
title Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts
title_full Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts
title_fullStr Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts
title_full_unstemmed Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts
title_short Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts
title_sort factors associated with rapidly deteriorating myelopathy in patients with spinal arteriovenous shunts
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841232/
https://www.ncbi.nlm.nih.gov/pubmed/34776462
http://dx.doi.org/10.2176/nmc.oa.2020-0439
work_keys_str_mv AT miyaharatakahiro factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT hattorigohsuke factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT uchikadohisaaki factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT kakuyasuyuki factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT ohmoriyuki factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT oritokimihiko factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT takeuchiyasuharu factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT kawanotakayuki factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT hirohatamasaru factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT mukasaakitake factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts
AT moriokamotohiro factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts